For immediate release
Radiant Genomics, Inc. Awarded an SBIR Phase I Grant
Emeryville, CA, February 26, 2015 – Radiant Genomics, Inc. is pleased to announce it has been awarded a Phase I Small Business Industrial Research (SBIR) grant from the National Center for Complementary & Integrative Health, part of the National Institutes of Health, for the project titled “Engineered Actinomycete Production Hosts for Heterologous Natural Product Discovery.”
“We are pleased with the continued support from the NIH towards our efforts to develop important technologies and tools for metagenomic natural product discovery,” said Dr. Jeffrey Kim, CSO of Radiant Genomics, Inc. “A significant hurdle to metagenomic natural product discovery is the robust production of natural products encoded by novel biosynthetic gene clusters using heterologous hosts. Metabolic engineering of production hosts is a key technology for making this consistent and repeatable. This grant will enable Radiant to both greatly enhance the production yield of existing production strains as well as expand the breadth of novel natural products that can be produced.”
About the Company
Radiant Genomics, Inc. was founded in 2012 with the goal of integrating a range of novel technologies including large-scale sequencing, synthetic biology, bioinformatics, cloud computing, metabolic engineering, and high-throughput analytical chemistry to develop a robust industrial platform for natural product discovery, diversification, and production. Radiant Genomics utilizes this platform to develop products in numerous market categories including pharmaceuticals, agriculture, specialty chemicals, and nutraceuticals.